Recent Quotes (30 days)

You have no recent quotes
chg | %

Takeda Pharmaceutical Co Ltd news

   Watch this stock
Showing stories 1 - 10 of about 122   

Articles published

4502 5,342.00 +15.00 (0.28%)
price chart
US FDA approves Takeda's lung cancer drug as second-line treatment
Japan's Takeda Pharmaceutical Co Ltd said on Friday that the U.S. Food and Drug Administration approved its lung cancer drug, almost three months after the company acquired the drug's developer, Ariad Pharmaceuticals Inc. The drug, Alunbrig, is ...
Takeda Announces FDA Accelerated Approval of ALUNBRIGTM (brigatinib)  Yahoo Finance
Ariad wins accelerated approval for second-line NSCLC drug brigatinib  BioWorld Online
Moody's confirms Takeda Pharmaceutical's A1 ratings; outlook negative
Takeda Pharmaceutical Company Limited is the largest pharmaceutical company in Japan in terms of revenue. It has well-established business franchises in Japan, the US and EU, and a presence in over 70 countries.
Takeda Completes Acquisition of ARIAD Pharmaceuticals, Inc.
CAMBRIDGE, Mass. & OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE:4502) (“Takeda”) today announced the completion of its acquisition of ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) (“ARIAD”) for $24.00 per share in ...
Takeda Pays 2012 Price For 2017 Model ARIAD
Takeda's (OTCPK:TKPHF) (OTCPK:TKPYY) $5.2bn takeout of ARIAD Pharmaceuticals (NASDAQ:ARIA) dents the hypothesis that biotechs with declining valuations will be the chief M&A targets of 2017.
Takeda is buying Ariad Pharmaceuticals in a $5.2 billion deal  Business Insider
BRIEF-Takeda Pharmaceutical says PRA Health Sciences and Takeda Partnership ...
Feb 15 Takeda Pharmaceutical Co Ltd : * Says PRA Health Sciences Inc and Takeda Pharmaceutical Company Limited have agreed to a new partnership to expand their global relationship initially disclosed in September 2016 to include Japan.
Takeda Enters into Strategic Collaboration with NuBiyota for Microbiome ...
OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TOKYO:4502) today announced a strategic collaboration with NuBiyota LLC for the development of Microbial Ecosystem Therapeutic products for gastroenterology (GI) ...
Valeant: Forget About Acquisition. Takeda Has Bought ARIAD
Takeda was planning an acquisition; however, instead of buying Valeant's Salix, the Japanese gastro-pharma bought ARIAD (NASDAQ:ARIA) - an oncological business with a strong pipeline and significant pricing power.
Harrington Discovery Institute Teams with Takeda for Advancement of Rare ...
"We believe Harrington Discovery Institute has a unique structure that is immensely helpful to academic researchers who are developing novel therapeutics that can result in significant impact for patients,” Daniel Curran, M.D.
BRIEF-Takeda Pharmaceutical completes acquisition of ARIAD Pharmaceuticals
BRIEF-Takeda Pharmaceutical completes acquisition of ARIAD Pharmaceuticals. Feb 17 Takeda Pharmaceutical Co Ltd : * Says co completes full acquisition of ARIAD Pharmaceuticals Inc on Feb. 16(U.
US FDA approves Takeda's lung cancer drug as 2nd-line treatment
April 28 Japan's Takeda Pharmaceutical Co Ltd said on Friday that the U.S. Food and Drug Administration approved its lung cancer drug, almost three months after the company acquired the drug's developer, Ariad Pharmaceuticals Inc. The drug, Alunbrig ...